Plasma Levels of Connective Tissue Growth Factor in Children with Congestive Heart Failure

Main Article Content

Riham Mahmoud Wagieh
Ahmed Hamdy Shabana
Hesham Mohammed Elserogy
Amr Mohamed Zoair


Objectives: Assessment of plasma level of connective tissue growth factor in congestive heart failure children, assessment of its diagnostic and prognostic role and correlate its level with clinical and echocardiographic assessment of congestive heart failure.

Methods: Connective tissue growth factor level in the plasma was measured in 40 children; 20 of them have congestive heart failure, and 20 are healthy then, correlated with clinical parameters.

Results: The diagnostic and prognostic value of it was evaluated. We compared its levels in both patients and healthy children. We found that connective tissue growth factor level was significantly increased in diseased children. Fractional shortening and ejection fraction correlated negatively with the plasma level of connective tissue growth factor. Heart rate, respiratory rate and calibrated integrated backscatter correlated positively with connective tissue growth factor. Connective tissue growth factor was significantly correlated with the class of heart failure according to Ross classification.

Conclusions: Plasma connective tissue growth factor has a promising diagnostic and prognostic value as a biomarker for congestive heart failure in children with high sensitivity and specificity.

Connective tissue growth factor, congestive heart failure, children.

Article Details

How to Cite
Wagieh, R. M., Shabana, A. H., Elserogy, H. M., & Zoair, A. M. (2020). Plasma Levels of Connective Tissue Growth Factor in Children with Congestive Heart Failure. Journal of Advances in Medicine and Medical Research, 32(1), 110-116.
Original Research Article


Hsu DT, Pearson GD. Heart failure in children: Part I: History, etiology and pathophysiology. Circ Heart Fail. 2009; 2:63–70.

Konstam MA, Udelson JE, Anand IS, Cohn JN. Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail. 2003;9:350–353.

Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart. 2004;90:464–470.

Chen CC, Lau LF. Functions and mechanisms of action of CCN matricellular proteins. Int. J. Biochem. Cell Biol; 2009; 41(4):771–83.

Shimo T, Nakanishi T, Nishida T, et al. Connective tissue growth factor induces the proliferation, migration and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem (Tokyo). 1999;126:137-45.

Miyazaki O, Kurashita S, Fukamachi I, et al. Subtraction method for determination of N-terminal connective tissue growth factor. Ann Clin Biochem. 2010;47:205-211.

Yang H, Huang Y, Chen X, Liu J, Lu Y, Bu L, et al. The role of CTGF in the diabetic rat retina and its relationship with VEGF and TGF-beta, elucidated by treatment with CTGF siRNA. Acta Ophthalmol. 2010;88:652-659.

Ross RD. The Ross classification for heart failure in children after 25 years: A review and an age-stratified revision. Pediatr Cardiol. 2012;33(8):1295-300.

Mizuno R, Fujimoto S, Saito Y, et al. Non-invasive quantitation of myocardial fibrosis using integrated backscatter analysis in dilated cardiomyopathy. Cardiology. 2007; 108:11-17.

Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, et al. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension. 2007; 49:1120–1127.

Shi-Wen X, Leask A, Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor. Rev. 2008;19:133–144.

Koitabashi N, Arai M, Kazuo Niwano , Atai Watanabe, et al. Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failre. Eur J Heart Fail; 2008;10(4):373-9.

Li G, Song X, Xia J, et al. The diagnostic value of plasma N-terminal connective tissue growth factor levels in children with heart failure. Cardiol Young. 2017; 27(1):101-108.